HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA semi-annual agenda

This article was originally published in The Rose Sheet

Executive Summary

Notice of proposed rulemaking for OTC UVA/UVB sunscreens is expected to be released this month, according to FDA's semi-annual agenda, published in an April 24 Federal Register 1notice. Agency anticipated a December 2005 release date for the rule in its last semi-annual agenda (2"The Rose Sheet" Nov. 7, 2005, In Brief). FDA partially stayed the OTC final sunscreen monograph in 2002 to develop UVA/UVB guidelines. Additional items on the semi-annual agenda include releasing NPRM for skin bleaching products this month and NPRM for OTC topical antimicrobial drug products in December. Final action on OTC dandruff, seborrheic dermatitis and psoriasis products is slated for August, and FDA aims to issue technical amendments to the final action on skin protectant products in June...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS013900

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel